Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature

Context: Metastatic pheochromocytoma/paraganglioma (MPP) therapy mainly involves radionuclide therapy, chemotherapy, and targeted therapy. In recent years, temozolomide (TMZ) showed great promise in some MMP patients, especially those with SDHB germline mutation. We reported a patient with MPP who d...

Full description

Bibliographic Details
Main Authors: Anli Tong, Ming Li, Yunying Cui, Xiaosen Ma, Huiping Wang, Yuxiu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Endocrinology
Subjects:
metastatic pheochromocytoma/paraganglioma
therapy
temozolomide
DNA Methylation
SDHB
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00061/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2020.00061/full

Similar Items